Approximately 500,000 Americans develop C. difficile infections each year, and about 30,000 die. Further, patients who make it through the severe diarrhea, nausea, fever and colitis C. difficile ...

EP: 12.Common Comorbidities Associated With Recurrent C Difficile Infections ...

VE303 is a potential first-in-class Live Biotherapeutic Product for the prevention of rCDI, which consists of a defined consortium of eight bacterial strains. Clinical results from Vedanta’s ...